Pancreatic Castleman disease treated with laparoscopic distal pancreatectomy

Filip Cecka1, Alexander Ferko, Bohumil Jon

  • 1Department of Surgery, Faculty of Medicine and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. filip.cecka@seznam.cz

Abstract

Insights

Castleman disease is a rare lymphoproliferative disorder. This case highlights laparoscopic distal pancreatectomy as a safe and effective treatment for rare pancreatic Castleman disease.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Pathology

Background:

  • Castleman disease is a rare lymphoproliferative disorder, typically affecting the mediastinum.
  • Pancreatic localization of Castleman disease is exceptionally rare, with only seventeen cases documented globally.
  • Abdominal presentations of Castleman disease are less common than mediastinal forms.

Observation:

  • A 48-year-old woman presented with epigastric pain and a pancreatic mass identified via CT scan.
  • Endosonography with fine needle aspiration biopsy revealed lymphoid elements consistent with a normal lymph node.
  • The pancreatic mass was surgically resected using a laparoscopic approach.

Findings:

  • The patient underwent a laparoscopic distal pancreatectomy for the rare pancreatic Castleman disease.
  • The pancreas was transected using a Ligasure device and secured with a manual suture.
  • Post-operative follow-up at one year showed the patient to be symptom-free with no signs of recurrence.

Implications:

  • Laparoscopic distal pancreatectomy is a viable and safe surgical option for pancreatic body and tail lesions.
  • Utilizing a Ligasure device for pancreatic transection minimizes bleeding and reduces the risk of pancreatic fistula.
  • This case contributes to the limited literature on managing extremely rare pancreatic Castleman disease.